Retatrutide 10mg

Retatrutide is an investigational peptide engineered as a triple receptor agonist. It is designed to engage three class B G-protein-coupled receptors at once, the GLP-1 receptor, the GIP receptor, and the glucagon receptor, activating the cyclic-AMP signaling cascades associated with each pathway. A lipidated incretin-analog backbone promotes albumin binding and gives the molecule an extended circulating half-life.

As one of the most closely watched compounds in the incretin field, retatrutide has been studied in the context of glucose metabolism, energy homeostasis, and hepatic lipid signaling. Signal supplies it as a research-grade reference material, with every batch tested for purity by HPLC and identity by mass spectrometry and traceable to a public certificate of analysis.